AMRN – amarin corporation plc - american depositary shares, each representing one ordinary share (US:NASDAQ)

News

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update
Amarin Announces Two Upcoming Investor Events
Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com